Director of Plx Pharma Inc. (NASDAQ:PLXP), Hadden John, buys 500 shares worth $2,738

According to Plx Pharma Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 04:08 PM, company Director, Hadden John disclosed buying 500 shares at a cost of $5.48. At the time of this transaction (Nov 25), this trade was worth $2,738 in total. As of Nov 25, Hadden John now owns 2,690 shares in total worth about $15,063.999999999998.

For the last few recent trades made by Plx Pharma Inc. (NASDAQ:PLXP) Director, Hadden John, we have the following information:

Posted by George Daniels on Wednesday November 25 2020, 6:19 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0